Skip to main content
Caplight Logo









Anocca

Anocca

Private
Södertälje, Stockholm CountyHealthcare & Life Scienceshttps://anocca.com

Last Round

Early Funding

Aug 18, 2025

Total Funding Raised

$82.65M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Anocca operates in Healthcare & Life Sciences and is based in Södertälje, Stockholm County. Its latest recorded funding round was an Early Funding round in August 2025.

Anocca is a clinical-stage biopharmaceutical company that develops T-cell receptor-engineered T cell (TCR-T) therapies to treat solid tumours and other diseases. Founded in 2014, the company has a fully integrated platform that includes research and development, a custom software ecosystem (AnoccaOS), and in-house cGMP manufacturing facilities in Södertälje, Sweden. Anocca's proprietary technology aims to scale the development of TCR-T cell therapies, enabling the systematic creation of personalized treatments for broad patient populations. The company is advancing its pipeline, with its lead program, VIDAR-1, in early-stage clinical trials for pancreatic cancer. Anocca is privately held and has received significant venture capital funding from investors including Mellby Gård, AMF, and Ramsbury.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Anocca Comparables

Compare Anocca with similar companies based on industry and business-model similarity.

Anocca comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Enara Bio
83%
ImmunoScape
81%
Affini-T Therapeutics
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Anocca Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingAug 18, 2025
Growth EquityMay 31, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Reagan Jarvis

Chief Executive Officer Co-founder

Founding Team

Jacob Michlewicz

Chief Financial Officer

Executive Team

Viktor Arnkil

Chief Operating Officer, Head of Operations

Executive Team

For institutional investors. Book with your work email.

Anocca Investors

Notable investors and investment history

Anocca investors
InvestorRounds
AMF TjänstepensionGrowth Equity
Mellby GårdEarly Funding, Growth Equity
Ramsbury InvestGrowth Equity
Swedbank RoburGrowth Equity
MichanoGrowth Equity
NidocoGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 1070% MoM, reaching 3.4K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • is_developingAug 25, 2026

    Anocca AB is developing precision T-cell receptor-engineered T-cell therapies targeting difficult-to-treat cancers.

Book a demo to see all news

For institutional investors. Book with your work email.

Anocca Filings

Explore SEC and related filing metadata, where available.

Anocca filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Anocca's valuation, stock price, and market status.

Is Anocca a public or private company?

Anocca is a private company.

What is the current stock price of Anocca?

Anocca is a private company, so its shares have no public market price. Caplight tracks Anocca's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Anocca worth (valuation)?

Valuation information for Anocca is not publicly available.

Can I buy Anocca stock?

Anocca shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Anocca's last funding round?

Anocca's most recent funding round was Early Funding on August 18, 2025.

Who are the main investors in Anocca?

Key investors in Anocca include AMF Tjänstepension, Mellby Gård.

Will Anocca IPO soon?

No public IPO plans have been announced for Anocca.

How can I track Anocca secondary market activity?

Caplight tracks bids, offers, and trades in Anocca's shares on secondary markets.

Firmographic Details

HeadquartersSödertälje, Stockholm County
Employee Range100
Year Founded2014
Last FundingAug 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?